It is demonstrated that oral cephradine can be dialysed.
表明头孢拉定能被透析清除。
CONCLUTION: The two cephradine capsules were of bioequivalence.
结论：两种头孢拉定胶囊具有生物等效性。
Results and Conclusions Using cephradine by high-dose or long-term is toxic to the kidney.
结果与结论大剂量或长期应用头孢拉定对肾脏有毒性。
RESULTS: The content of high molecular weight impurities in Cephradine Capsule is less than (0.5) %.
结果：头孢拉定胶囊的高分子杂质含量均小于0.5%。
Methods Through literature search and selection, the causes of renal ADRs of cephradine were analyzed, and preventive measures were recommended.
方法通过对文献检索和筛选，分析头孢拉定肾脏不良反应的原因，总结转归及预防。
OBJECTIVE To reduce the particle size and thus improve the quality of cephradine by adopting high gravity technology in the crystalline process.
目的制备超细头孢拉定结晶颗粒，以提高产品质量。
Methods: Adopt UV separate established standard curve and determined recycle rate and observed stability of Cephradine in Tinidazole at varying time.
方法：采用紫外分光光度法建立两者的标准曲线和测定回收率，并观察不同温度下、不同时间的配伍稳定性。
Methods:230 patients were divided randomly into two groups:120 patients in treatment group treated by Beautyberry Pills and 110 patients in control group treated by Cephradine Capsules.
方法：230例患者随机分为治疗组120例，应用裸花紫珠片治疗；对照组110例，应用头孢拉啶胶囊治疗。
Methods:230 patients were divided randomly into two groups:120 patients in treatment group treated by Beautyberry Pills and 110 patients in control group treated by Cephradine Capsules.
方法：230例患者随机分为治疗组120例，应用裸花紫珠片治疗；对照组110例，应用头孢拉啶胶囊治疗。
应用推荐